Yellowstone Holding
Europe, Geneve, Switzerland, Versoix
Description
Yellowstone Holding promoting new innovative products or technologies from Switzerland to the Asia market via our strong connections.
Investor Profile
Yellowstone Holding has backed more than 7 startups, with 0 new investments in the last 12 months alone. The firm has led 5 rounds, about 71% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Series Unknown rounds (top funding stages).
- Majority of deals are located in Switzerland, Germany, United States.
- Strong thematic focus on Health Care, Medical, Biotechnology.
Stage Focus
- Series A (43%)
- Series B (29%)
- Series Unknown (14%)
- Series C (14%)
Country Focus
- Switzerland (57%)
- Germany (14%)
- United States (14%)
- Taiwan (14%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(60)'/%3e%3ccircle r='17' fill='%23000095'/%3e%3ccircle r='15' fill='%23fff'/%3e%3c/svg%3e)
Industry Focus
- Health Care
- Medical
- Biotechnology
- Medical Device
- Manufacturing
- Navigation
- Beauty
- Cosmetics
- Clinical Trials
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3c/g%3e%3cuse xlink:href='%23d' x='45.714'/%3e%3cuse xlink:href='%23e' transform='matrix(-1 0 0 1 479.792 0)'/%3e%3cg id='f' fill='%23fff'%3e%3cpath fill='%23039' d='M232.636 202.406v.005c0 2.212.85 4.227 2.212 5.69 1.365 1.466 3.245 2.377 5.302 2.377 2.067 0 3.944-.905 5.303-2.365 1.358-1.459 2.202-3.472 2.202-5.693v-10.768l-14.992-.013-.028 10.766'/%3e%3ccircle cx='236.074' cy='195.735' r='1.486'/%3e%3ccircle cx='244.392' cy='195.742' r='1.486'/%3e%3ccircle cx='240.225' cy='199.735' r='1.486'/%3e%3ccircle cx='236.074' cy='203.916' r='1.486'/%3e%3ccircle cx='244.383' cy='203.905' r='1.486'/%3e%3c/g%3e%3cuse xlink:href='%23f' y='-26.016'/%3e%3cuse xlink:href='%23f' x='-20.799'/%3e%3cuse xlink:href='%23f' x='20.745'/%3e%3cuse xlink:href='%23f' y='25.784'/%3e%3c/svg%3e)
